Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Oral discomfort, Oropharyngeal discomfort, Pain assessment, Pain in jaw
Clinical narrative: same symptoms but less severe\very bad feeling in the head; same symptoms but less severe\,very bad feeling back of the throat and lips; same symptoms but less severe\didn't feel good enough to do anything; same symptoms but less severe\,very bad feeling back of the throat; same symptoms but less severe\chest pain; same symptoms but less severe\high blood pressure; same symptoms but less severe\shortness of breath; same symptoms but less severe\jaw pain; same symptoms but less severe/feeling like anxiety; same symptoms but les/barely walk; numbness of her lips; Tingling of lips; same symptoms but less severe\fatigue; same symptoms but less severe\between the shoulder blades with pain number 2 and head number 6; same symptoms but less severe\headache; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (same symptoms but less severe\very bad feeling in the head), ORAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat and lips), VACCINATION COMPLICATION (same symptoms but less severe\didn't feel good enough to do anything), OROPHARYNGEAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat) and CHEST PAIN (same symptoms but less severe\chest pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Renal calculi, Hypothyroidism and Knee fracture. Concurrent medical conditions included Coronary artery disease, Type 2 diabetes mellitus, Sleep apnea, Hypertension, Atrial fibrillation and Anxiety. Concomitant products included FERROUS SULPHATE [FERROUS SULFATE] and ASCORBIC ACID for Anemia, OMEPRAZOLE for Barrett's esophagus, POTASSIUM CHLORIDE for Cardiac disorder, ATORVASTATIN for Cholesterol, FUROSEMIDE (LASIX [FUROSEMIDE]) and MAGNESIUM OXIDE for Heart disorder, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, LEVOTHYROXINE for Thyroid therapy, VITAMIN D [VITAMIN D NOS], MULTIVITAMIN [VITAMINS NOS], FISH OIL and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (same symptoms but less severe\very bad feeling in the head), ORAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat and lips), VACCINATION COMPLICATION (same symptoms but less severe\didn't feel good enough to do anything), OROPHARYNGEAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat), CHEST PAIN (same symptoms but less severe\chest pain), HYPERTENSION (same symptoms but less severe\high blood pressure), DYSPNOEA (same symptoms but less severe\shortness of breath), PAIN IN JAW (same symptoms but less severe\jaw pain), ANXIETY (same symptoms but less severe/feeling like anxiety), GAIT DISTURBANCE (same symptoms but les/barely walk), HYPOAESTHESIA ORAL (numbness of her lips), PARAESTHESIA ORAL (Tingling of lips), FATIGUE (same symptoms but less severe\fatigue), ARTHRALGIA (same symptoms but less severe\between the shoulder blades with pain number 2 and head number 6) and HEADACHE (same symptoms but less severe\headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) on 17-Feb-2021 at a dose of 25 milligram; APIXABAN (ELIQUIS) ongoing since an unknown date at an unspecified dose and frequency; ISOSORBIDE MONONITRATE (IMDUR) at a dose of Daily; ACETYLSALICYLIC ACID (BABY ASPIRIN) ongoing since an unknown date at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 2 ES. On 24-Feb-2021, HEAD DISCOMFORT (same symptoms but less severe\very bad feeling in the head), ORAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat and lips), VACCINATION COMPLICATION (same symptoms but less severe\didn't feel good enough to do anything), OROPHARYNGEAL DISCOMFORT (same symptoms but less severe\,very bad feeling back of the throat), CHEST PAIN (same symptoms but less severe\chest pain), HYPERTENSION (same symptoms but less severe\high blood pressure), DYSPNOEA (same symptoms but less severe\shortness of breath), PAIN IN JAW (same symptoms but less severe\jaw pain), ANXIETY (same symptoms but less severe/feeling like anxiety), GAIT DISTURBANCE (same symptoms but les/barely walk), HYPOAESTHESIA ORAL (numbness of her lips), PARAESTHESIA ORAL (Tingling of lips), FATIGUE (same symptoms but less severe\fatigue), ARTHRALGIA (same symptoms but less severe\between the shoulder blades with pain number 2 and head number 6) and HEADACHE (same symptoms but less severe\headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 136/75 (High) BP 136/75. On an unknown date, Pain assessment: 3/10 (Low) 3/10 chest pressure and 6/10 (High) 6/10 headache lasted until 24-FEB-2021.         Patient medical history includes-pacemaker, status post ablation 2010 and 2013 of the right outflow tract, hype her parathyroidism and RCA stent in 2011. Patient lab data initial heart monitor and chest x-ray was provided. Patient used CPAP machine at bedtime. At the Emergency room patient had rectal pressure initially and need of immediate bowel movement(not diarrhea). Patient experienced pulse 90s when winded walking up stairs. Patient experienced achy as residual effects.   This case was linked to MOD21-058406 (E2B Linked Report). This case was linked to MOD-2021-051942 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Significant Follow up  received 23-JUL-2021. Patient medical history was updated. Lab data was updated. Concomitant medications were added. Treatment medications were added. New events-Numbness of lips and tingling of lips was updated. Event stop date was updated.; Sender's Comments:  MOD21-058406:Same reporter, different patient